Home › NDC Lookup › RxCUI directory › RxCUI 2587906

Molnupiravir 200 MG Oral Capsule — RxCUI 2587906

RxNorm drug concept · Semantic clinical drug
RxCUI 2587906 Semantic clinical drug · SCD ● Current RxNorm concept 1 FDA product 3 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI2587906
Official nameMolnupiravir 200 MG Oral Capsule
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known asmolnupiravir 200 MG Oral Capsule (EUA)
FDA products mapped1
Package NDCs mapped3
Reported Medicaid activity (SDUD)597 prescriptions · 6 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Molnupiravir: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • Lagevrio is an antiviral pill that works by scrambling the COVID-19 virus's ability to copy itself — basically causing it to make so many mistakes it can't survive. Your doctor pre...
  • What exactly is Lagevrio and why did my doctor prescribe it for COVID-19?
  • You take Lagevrio twice a day — roughly every 12 hours — for exactly 5 days. You can take it with or without food, whichever is easier for you. The most important thing is to start...
  • How do I take it, and does it matter if I take it with food?
📖 Read our full Molnupiravir guide →

🕸️ Concept Web — How Molnupiravir 200 MG Oral Capsule Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Molnupiravir 200 MG Oral Capsule RxCUI 2587906

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Molnupiravir 2587901
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Lagevrio 2603735
  3. Dose forms 9

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Molnupiravir Oral Capsule 2587905
    • Molnupiravir Oral Product 2587903
    • Molnupiravir Pill 2587904
    • Molnupiravir Oral Capsule [Lagevrio] 2603739
    • Lagevrio Oral Product 2603737
    • Lagevrio Pill 2603738
    • Oral Capsule 316965
    • Oral Product 1151131
    • +1 more in this family
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 13 of 14 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Molnupiravir 200 MG SCDC · 2587902
  • Molnupiravir Oral Capsule SCDF · 2587905
  • Molnupiravir Oral Product SCDG · 2587903
  • Molnupiravir Pill SCDG · 2587904

Brand-Name Concepts

  • Molnupiravir 200 MG Oral Capsule [Lagevrio] SBD · 2603740
  • Molnupiravir 200 MG [Lagevrio] SBDC · 2603736
  • Molnupiravir Oral Capsule [Lagevrio] SBDF · 2603739
  • Lagevrio Oral Product SBDG · 2603737
  • Lagevrio Pill SBDG · 2603738
  • Lagevrio BN · 2603735

📦 FDA Products & Package NDCs

1 product · 3 package NDCs
3 package NDCs map to RxCUI 2587906 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
00006-5055-06 40 CAPSULE in 1 BOTTLE, PLASTIC (0006-5055-06) LAGEVRIO Merck Sharp & Dohme LLC 2021-12-23
00006-5055-07 40 CAPSULE in 1 BOTTLE, PLASTIC (0006-5055-07) LAGEVRIO Merck Sharp & Dohme LLC 2021-12-23
00006-5055-09 40 CAPSULE in 1 BOTTLE, PLASTIC (0006-5055-09) LAGEVRIO Merck Sharp & Dohme LLC 2023-02-01
Observed labelers: Merck Sharp & Dohme LLC (3) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.